This is an intelligent monitoring tool designed to support clinicians in keeping a close, ongoing watch over patients after ...
Dr Hannah McManus looks ahead to the release of new data from phase 3 clinical trials that will inform multidisciplinary ...
A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active ...
Getting life insurance after cancer depends on the cancer type, grade, treatment and timing ...
Many cancer patients turn to biotin supplements hoping to restore hair lost during treatment, but experts warn the popular ...
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve outcomes for patients with ...
A POPULAR supplement taken by many may interfere with medical testing for cancer and even cause inaccurate results, experts ...
Ultimately, making RWE actionable means shortening the gap between insight and application. When data is reliable, complete, and easy to use, it can support better decisions, faster adoption of new ...
Can the new GLP-1s help prevent cancer before it starts by tackling obesity and all the dysfunctional metabolic pathways that ...
US FDA’s ODA committee recommends approval of AstraZeneca’s Truqap for PTEN-deficient metastatic hormone-sensitive prostate cancer: Cambridge, UK Monday, May 4, 2026, 17:00 Hr ...
Every single type of cancer, explained A cancer diagnosis can be both terrifying and confusing for those afflicted, as well ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results